neuropharmacology

HIV Drugs Show Promise in Reducing Alzheimer’s Disease Risk, Study Finds

by
HIV Drugs Show Promise in Reducing Alzheimer’s Disease Risk, Study Finds

Common HIV Drugs Show Potential in Reducing Alzheimer’s Disease, Study Finds Summary Groundbreaking research has revealed that common HIV drugs, specifically reverse transcriptase (RT) inhibitors, have the potential to decrease the occurrence of Alzheimer’s disease (AD) in patients. The study, based on anonymized prescription data from over 225,000 individuals, found that HIV-positive patients taking RT … Read more

Breakthrough Compound LY2444296 Shows Promise in Treating Alcohol Use Disorder, According to Study

by
Breakthrough Compound LY2444296 Shows Promise in Treating Alcohol Use Disorder, According to Study

Breakthrough Compound Shows Promise in Treating Alcohol Use Disorder Key Facts: LY2444296 targets the kappa opioid receptor, showing potential to reduce alcohol consumption in rats with alcohol dependence without affecting non-dependent rats. The compound successfully decreased withdrawal symptoms and alcohol intake after just 8 hours of abstinence, a critical period for withdrawal onset. Funded by … Read more